| pubmed-article:3792938 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3792938 | lifeskim:mentions | umls-concept:C0476089 | lld:lifeskim |
| pubmed-article:3792938 | lifeskim:mentions | umls-concept:C0441771 | lld:lifeskim |
| pubmed-article:3792938 | lifeskim:mentions | umls-concept:C1552617 | lld:lifeskim |
| pubmed-article:3792938 | lifeskim:mentions | umls-concept:C0282443 | lld:lifeskim |
| pubmed-article:3792938 | lifeskim:mentions | umls-concept:C0868928 | lld:lifeskim |
| pubmed-article:3792938 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:3792938 | pubmed:dateCreated | 1987-1-29 | lld:pubmed |
| pubmed-article:3792938 | pubmed:abstractText | Forty-one patients with clinical-pathological stage III carcinoma of the endometrium treated between January 1958 and December 1983 at the Ottawa General Hospital were analyzed. Twenty-three patients (56%) presented with clinical stage III and 18 (44%) with pathological stage III. The 5-year survival of all stage III patients was 35%. Patients with clinical stage III had a 5-year survival of 8% compared to 70% for patients with pathological stage III (P less than 0.01). Twenty-nine patients (71%) failed. The site of first recurrence was limited to the abdominal cavity in all but 6 patients (79%). The role of whole abdominal radiation is discussed. | lld:pubmed |
| pubmed-article:3792938 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3792938 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3792938 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:3792938 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3792938 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:3792938 | pubmed:issn | 0090-8258 | lld:pubmed |
| pubmed-article:3792938 | pubmed:author | pubmed-author:GenestPP | lld:pubmed |
| pubmed-article:3792938 | pubmed:author | pubmed-author:GirardAA | lld:pubmed |
| pubmed-article:3792938 | pubmed:author | pubmed-author:DrouinPP | lld:pubmed |
| pubmed-article:3792938 | pubmed:author | pubmed-author:GerinGG | lld:pubmed |
| pubmed-article:3792938 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3792938 | pubmed:volume | 26 | lld:pubmed |
| pubmed-article:3792938 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3792938 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3792938 | pubmed:pagination | 77-86 | lld:pubmed |
| pubmed-article:3792938 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:3792938 | pubmed:meshHeading | pubmed-meshheading:3792938-... | lld:pubmed |
| pubmed-article:3792938 | pubmed:meshHeading | pubmed-meshheading:3792938-... | lld:pubmed |
| pubmed-article:3792938 | pubmed:meshHeading | pubmed-meshheading:3792938-... | lld:pubmed |
| pubmed-article:3792938 | pubmed:meshHeading | pubmed-meshheading:3792938-... | lld:pubmed |
| pubmed-article:3792938 | pubmed:meshHeading | pubmed-meshheading:3792938-... | lld:pubmed |
| pubmed-article:3792938 | pubmed:meshHeading | pubmed-meshheading:3792938-... | lld:pubmed |
| pubmed-article:3792938 | pubmed:meshHeading | pubmed-meshheading:3792938-... | lld:pubmed |
| pubmed-article:3792938 | pubmed:meshHeading | pubmed-meshheading:3792938-... | lld:pubmed |
| pubmed-article:3792938 | pubmed:meshHeading | pubmed-meshheading:3792938-... | lld:pubmed |
| pubmed-article:3792938 | pubmed:meshHeading | pubmed-meshheading:3792938-... | lld:pubmed |
| pubmed-article:3792938 | pubmed:meshHeading | pubmed-meshheading:3792938-... | lld:pubmed |
| pubmed-article:3792938 | pubmed:meshHeading | pubmed-meshheading:3792938-... | lld:pubmed |
| pubmed-article:3792938 | pubmed:year | 1987 | lld:pubmed |
| pubmed-article:3792938 | pubmed:articleTitle | Stage III carcinoma of the endometrium: a review of 41 cases. | lld:pubmed |
| pubmed-article:3792938 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3792938 | lld:pubmed |
